The International Porphyrias Symposium 2023, where experts discuss the latest research into porphyria, will be held later this…
Marisa Horak, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Horak, MS
An unusual case of acute intermittent porphyria (AIP) that was marked by seizures was described in a recent case…
Scientists in Switzerland have reported the first documented case of acute intermittent porphyria (AIP) caused by a mosaic mutation…
Plasma exchange — a procedure that involves replacing the liquid portion of blood, not blood cells — effectively eased motor…
Certain people with acute hepatic porphyria (AHP) living in British Columbia may now get full coverage of Givlaari…
A probiotic supplement led to improvements in blood sugar and insulin levels and increased heme production in a mouse model…
An infant in Brazil who developed severe skin blistering after receiving a light-based therapy for jaundice, or yellowing of the…
A screening program at emergency departments may help to more efficiently diagnose acute forms of porphyria, according to a…
Treatment with the implantable medication Scenesse (afamelanotide), which is approved to help reduce light intolerance in people with erythropoietic…
When patients have unusual sunlight sensitivity combined with liver damage, the possible diagnosis of erythropoietic protoporphyria (EPP) should be…